Resistance to conventional chemotherapy remains a major obstacle in the treatment of lung cancer and is largely driven by cancer stem-like cells (CSCs). Here, we investigated the molecular mechanisms underlying the anticancer activity of a hydroxylated chalcone derivative (UR-2) using CD133+ lung cancer organoid and xenograft models. Quantitative proteomic profiling identified mitochondrial Thioredoxin-2 (TRX2), encoded by the TXN2 gene, as a key regulator of UR-2-induced redox signaling.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile